Why is Tatva Chintan falling/rising?

As of 22-Sep, Tatva Chintan Pharma Chem Ltd is currently priced at 1,099.55, reflecting a decrease of 3.45 points or 0.31%. Despite this decline, the stock has shown a strong performance over the past week, with a return of 3.52%, and has outperformed its sector by 0.52% today. However, there has been a notable drop in investor participation, with delivery volume falling by 51.3% compared to the 5-day average. The stock has also been trading above its moving averages across various time frames, indicating some underlying strength. Over the last year, Tatva Chintan has managed to generate a return of 12.11%, significantly outperforming the broader market, which has seen negative returns.
In the broader market context, while the stock has experienced a slight decline today, its recent performance has been robust compared to the benchmark, as it has outperformed the BSE500, which has recorded a negative return of 3.80% over the past year. The company's low debt-to-equity ratio of 0.07 times and the fact that the majority shareholders are promoters suggest a stable financial position, which could support future growth. However, the significant drop in delivery volume may raise concerns about liquidity and investor confidence, contributing to the current price movement.